Cingulate Inc. (CING) shareholders
CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
$4.64+0.08 (+1.75%)
Close on Nov 11, 2026Market cap $67.47MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
2M
Shares held, 13F filers
Institutional holders
33
10 new, 4 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
5 buys · 0 sales
Net bought $656.96K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Falcon Creek Capital Advisor LLC Joint filing with Ginkgo Capital Global Fund SPC - Xtalpi AI Fund SP (25.91%) | 3,856,766 | 28.50% | 13D (active) amendment | Mar 24, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CING | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 570,873 | – | $3.12M | +261,906 | 0.00% |
| Chicago Partners Investment Group LLC | 188,429 | – | $912.00K | +169,679 | 0.02% |
| Raymond James Financial Inc | 166,898 | – | $912.93K | New | 0.00% |
| Kestra Advisory Services, LLC | 151,500 | – | $828.71K | +11,500 | 0.00% |
| Geode Capital Management, LLC | 144,636 | – | $791.37K | +43,263 | 0.00% |
| Renaissance Technologies LLC | 127,500 | – | $697.43K | +95,612 | 0.00% |
| Vanguard Fiduciary Trust Co | 79,160 | – | $433.01K | +29,086 | 0.00% |
| BlackRock, Inc. | 53,130 | – | $290.62K | +29,861 | 0.00% |
| BCV Asset Management Inc. | 51,200 | – | $272.94K | – | 0.01% |
| State Street Corp | 47,888 | – | $261.95K | +20,300 | 0.00% |
| Northern Trust Corp | 35,121 | – | $192.11K | +12,849 | 0.00% |
| Quantum Private Wealth, LLC | 30,000 | – | $164.10K | +20,000 | 0.04% |
| Prospera Financial Services Inc | 29,900 | – | $163.55K | +8,100 | 0.00% |
| Jane Street Group, LLC | 28,878 | – | $157.96K | −61,989 | 0.00% |
| UBS Group AG | 25,947 | – | $141.93K | +14,914 | 0.00% |
| Mariner, LLC | 21,281 | – | $116.41K | +8,351 | 0.00% |
| XTX Topco Ltd | 20,818 | – | $113.87K | −32,685 | 0.00% |
| Jump Financial, LLC | 14,638 | – | $80.07K | New | 0.00% |
| Virtu Financial LLC | 12,056 | – | $66.00K | −15,472 | 0.00% |
| PKS Advisory Services, LLC | 11,500 | – | $62.91K | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 33 | 2M | 10 / 15 | 4 / 4 | 1M | 0M |
| Q1 2026 | 27 | 1M | 14 / 7 | 3 / 4 | 1M | 0M |
| Q4 2025 | 18 | 1M | 7 / 6 | 4 / 1 | 0M | 0M |
| Q3 2025 | 12 | 0M | 3 / 5 | 4 / 6 | 0M | 0M |
| Q2 2025 | 15 | 0M | 6 / 5 | 2 / 0 | 0M | 0M |
| Q1 2025 | 9 | 0M | 2 / 5 | 1 / 1 | 0M | 0M |
| Q4 2024 | 9 | 0M | 3 / 3 | 3 / 4 | 0M | 0M |
| Q3 2024 | 10 | 0M | 10 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
12 funds held CING in Q2 2026, 86% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CING | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 394,555 | – | $2.16M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 160,396 | – | $877.37K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 42,839 | – | $178.21K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 27,990 | – | $153.11K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 22,533 | – | $93.74K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 10,991 | – | $45.72K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 10,246 | – | $56.05K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 8,474 | – | $35.25K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 5,676 | – | $31.05K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 1,871 | – | $10.23K | 0.00% | Jun 30, 2026 |
| Total Stock Market Index Trust | 246 | – | $1.35K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -4,100 | – | -$22.43K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Shane J. Schaffer | Chief Executive Officer, Director | 17,210 | Jul 20, 2026 |
| Raul R. Silva | EVP and CSO | 4,645 | Oct 2, 2026 |
| Matthew Brams | EVP and Chief Medical Officer | 9,182 | Jul 20, 2026 |
| Jennifer L. Callahan | EVP and CFO | 20,388 | Jul 20, 2026 |
| Bryan Wade Downey | EVP & Chief Commercial Officer | – | Jul 20, 2026 |
| Nilay Dahyabhai Patel | EVP, CLO and CCO | 5,475 | Mar 11, 2026 |
| Laurie Myers | EVP and COO | 0 | Jul 9, 2025 |
| Peter J. Werth | Director | 117,541 | Jul 20, 2026 |
| Bryan Jay Lawrence | Director | – | Jul 20, 2026 |
| Thomas Jeffrey Hargroves | Director | 105,768 | Jul 20, 2026 |
| John A. Roberts | Director | – | Jun 23, 2025 |
| Jeffrey S. Ervin | Director | – | Jun 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Shane J. Schaffer Chief Executive Officer, Director | Mar 9, 2026 | Award | +6,862 | – | – | 7,035 |
| Shane J. Schaffer Chief Executive Officer, Director | Mar 9, 2026 | Tax withholding | −2,959 | – | – | 4,076 |
| Jennifer L. Callahan EVP and CFO | Mar 9, 2026 | Award | +15,329 | – | – | 20,388 |
| Jennifer L. Callahan EVP and CFO | Mar 9, 2026 | Tax withholding | −6,427 | – | – | 13,961 |
| Nilay Dahyabhai Patel EVP, CLO and CCO | Mar 9, 2026 | Award | +5,475 | – | – | 5,475 |
| Nilay Dahyabhai Patel EVP, CLO and CCO | Mar 9, 2026 | Tax withholding | −2,086 | – | – | 3,389 |
| Matthew Brams EVP and Chief Medical Officer | Mar 9, 2026 | Award | +4,526 | – | – | 9,182 |
| Matthew Brams EVP and Chief Medical Officer | Mar 9, 2026 | Tax withholding | −1,025 | – | – | 8,157 |
| Raul R. Silva EVP and CSO | Mar 9, 2026 | Tax withholding | −1,828 | – | – | 4,645 |
| Raul R. Silva EVP and CSO | Mar 9, 2026 | Award | +4,526 | – | – | 6,473 |
| Thomas Jeffrey Hargroves Director | Feb 13, 2026 | Buy | +97,276 | $5.04 | $490.27K | 97,468 |
| Matthew Brams EVP and Chief Medical Officer | Feb 6, 2026 | Buy | +1,946 | $5.04 | $9.81K | 4,656 |
| Shane J. Schaffer Chief Executive Officer, Director | Feb 6, 2026 | Buy | +6,809 | $5.04 | $34.32K | 10,175 |
| Jennifer L. Callahan SVP and CFO | Feb 6, 2026 | Buy | +4,864 | $5.04 | $24.51K | 5,059 |
| Peter J. Werth Director | Feb 6, 2026 | Buy | +19,455 | $5.04 | $98.05K | 117,449 |
| Laurie Myers EVP and COO | Aug 15, 2024 | Sale | −202 | $4.17 | $842 | 0 |
| Peter J. Werth Director, 10% owner | Apr 11, 2024 | Option exercise | +694,096 | – | – | 1,175,925 |
| Peter J. Werth Director, 10% owner | Apr 11, 2024 | Option exercise | +341,912 | – | – | 481,829 |
| Jennifer L. Callahan Corporate Controller | Sep 15, 2023 | Buy | +5,000 | $0.67 | $3.35K | 45,508 |
| Peter J. Werth Director | Aug 11, 2023 | Buy | +1,823,155 | $0.55 | $1.00M | 2,798,320 |
| Jennifer L. Callahan Corporate Controller | May 15, 2023 | Buy | +2,000 | $1.01 | $2.02K | 40,508 |
| Jennifer L. Callahan Corporate Controller | May 12, 2023 | Buy | +4,000 | $1.08 | $4.32K | 38,508 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 16, 2022 | Buy | +10,000 | $1.02 | $10.20K | 41,500 |
| Jennifer L. Callahan Corporate Controller | Dec 14, 2022 | Buy | +7,548 | $0.99 | $7.47K | 34,508 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 14, 2022 | Buy | +13,267 | $1.01 | $13.40K | 31,500 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 13, 2022 | Buy | +1,733 | $1.01 | $1.75K | 18,233 |
| Peter J. Werth Director | Dec 13, 2022 | Buy | +28,934 | $0.98 | $28.36K | 975,165 |
| Jennifer L. Callahan Corporate Controller | Nov 29, 2022 | Buy | +1,530 | $0.98 | $1.50K | 26,960 |
| Jennifer L. Callahan Corporate Controller | Nov 28, 2022 | Buy | +3,487 | $0.98 | $3.42K | 25,430 |
| Laurie Myers EVP and COO | Nov 23, 2022 | Buy | +1,111 | $0.90 | $1,000 | 48,263 |
| Craig S. Gilgallon EVP, GC and Secretary | Nov 23, 2022 | Buy | +3,575 | $0.84 | $3.00K | 9,550 |
| Gregg Wm Givens Director | Nov 22, 2022 | Buy | +85,000 | $0.88 | $74.80K | 154,318 |
| Jennifer L. Callahan Corporate Controller | Sep 8, 2022 | Buy | +3,500 | $1.50 | $5.25K | 21,943 |
| Peter J. Werth Director | Sep 6, 2022 | Buy | +74,500 | $1.52 | $113.24K | 946,231 |
| Laurie Myers EVP and COO | Sep 1, 2022 | Buy | +636 | $1.57 | $999 | 47,352 |
| Laurie Myers EVP and COO | Jun 1, 2022 | Buy | +200 | $1.18 | $236 | 46,716 |
| Laurie Myers EVP and COO | May 24, 2022 | Gift | −200 | – | – | 47,152 |
| Laurie Myers EVP and COO | May 17, 2022 | Buy | +200 | $1.21 | $242 | 46,516 |
| Curtis Medeiros Director | May 6, 2022 | Sale | −17,532 | $1.27 | $22.27K | 0 |
| Peter J. Werth Director | Mar 17, 2022 | Buy | +27,000 | $1.79 | $48.33K | 871,731 |
| Laurie Myers EVP and COO | Mar 16, 2022 | Buy | +353 | $1.40 | $494 | 46,316 |
| Jennifer L. Callahan Corporate Controller | Mar 16, 2022 | Buy | +1,900 | $1.39 | $2.64K | 18,443 |
| Jennifer L. Callahan SVP and CFO | Mar 15, 2022 | Buy | +55 | $27.10 | $1.49K | 2,333 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +4,000 | $1.37 | $5.48K | 10,000 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +4,000 | $1.37 | $5.48K | 10,000 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +27,000 | $1.38 | $37.26K | 69,318 |
| Gregg Wm Givens Director | Mar 15, 2022 | Buy | +4,000 | $1.38 | $5.52K | 10,000 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +9,000 | $1.32 | $11.88K | 42,318 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +6,000 | $1.30 | $7.80K | 6,000 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +6,000 | $1.30 | $7.80K | 6,000 |
| Gregg Wm Givens Director | Mar 14, 2022 | Buy | +6,000 | $1.29 | $7.74K | 6,000 |
| Horn Louis G. Van EVP and CFO | Mar 14, 2022 | Buy | +15,000 | $1.34 | $20.10K | 15,000 |
| Curtis Medeiros Director | Mar 14, 2022 | Buy | +17,532 | $1.41 | $24.72K | 17,532 |
| Jennifer L. Callahan Corporate Controller | Mar 14, 2022 | Buy | +12,000 | $1.46 | $17.52K | 16,543 |
| Craig S. Gilgallon EVP & General Counsel | Mar 14, 2022 | Buy | +5,975 | $1.38 | $8.25K | 5,975 |
| Peter J. Werth Director | Dec 10, 2021 | Buy | +8,300 | – | – | 844,731 |
| Thomas Jeffrey Hargroves Director | Dec 10, 2021 | Buy | +8,300 | – | – | 8,300 |
| Gregg Wm Givens Director | Dec 10, 2021 | Buy | +16,500 | – | – | 33,318 |
| Shane J. Schaffer Chief Executive Officer, Director | Dec 10, 2021 | Buy | +16,500 | – | – | 16,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
1M shares short
Days to cover
7.5
At 0M shares a day
Change since last report
+2.0%
From 1M shares
Short volume, 20 days
39.1%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cingulate's stock actually held short. Settlement fails (shares not delivered on time) peaked at 11,258 shares on Sep 29, 2026 over the last 90 days.
See a number that looks wrong?